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This Month in the Journal
O’Donovan and Owen (p. 587) begin this month’s series
on genetic aspects of psychiatric conditions and treat-
ment. They consider the merits of linkage and associa-
tion studies for identifying genes related to schizophrenia
and similar complex but heritable disorders, and they
focus on three potentially relevant genes, including one,
KCa3, that has generated both excitement and contro-
versy in the past 2 years. Shih and Thompson (p. 593)
discusses their work in a mouse system that models the
pathological aggression seen in a large family segregating
a mutation in the X–linked monoamine oxidase A
(MAOA) gene. MAO A is required for the efficient deg-
radation of serotonin and other neurotransmitters, and
the absence of this activity causes similar metabolic and
behavioral consequences in mice and humans. Reich et
al. (p. 599) review the genetics of substance dependence
and, especially, of alcoholism. These authors argue that
comorbidity among different addictive behaviors makes
it difficult to distinguish whether genes control them in-
dividually. Nevertheless, they suggest that large ongoing
studies, such as the Collaborative Study on the Genetics
of Alcoholism (COGA; data and materials from which
are to be made public this month), have already provided
crucial insights into the inheritance of this class of sub-
stance dependence. Finally, Catalano (p. 606) reviews
the promise and the challenges of the new—or newly
revitalized—field of psychopharmacogenetics, which
aims to tailor psychiatric drug therapies to individuals
on the basis of their genotype.
Stop-Codon Mutation in COX I Gene, by Bruno et al.
(p. 611)
Most disease-associated mtDNA lesions directly affect
the protein biosynthetic machinery in the mitochondrion
and only indirectly interfere with oxidative phosphor-
ylation. However, there is a growing list of point mu-
tations and small deletions that occur in mitochondrially
encoded structural genes for subunits of the respiratory
complexes. Bruno et al. have identified a novel mutation
in this class, a nonsense mutation that truncates the open
reading frame of COX I, which encodes the largest sub-
unit of complex IV. This lesion is present in ∼75% of
the mtDNA molecules in tissues of a woman who dis-
plays many of the hallmarks of mitochondrial disease,
and the authors have generated transmitochondrial cy-
brids with varying proportions of wild-type mtDNA and
mtDNA carrying this mutation. In this report, they show
that 65% mutant mtDNA is sufficient to reduce the ef-
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ficiency of oxidative phosphorylation by 90%. In these
cybrids, the mutant protein does not accumulate to a
detectable level, despite the presence of normal amounts
of COX I mRNA. Bruno et al. suggest that the truncated
protein is unstable and is degraded by endogenous pro-
teinases because it fails to assemble with the other sub-
units of complex IV.
Splice-Donor–Site Mutation in COLQ, by Ohno et al.
(p. 635)
In the course of studying a patient with congenital end-
plate cholinesterase (AChE) deficiency, Ohno et al. have
identified an unusual splicing defect in the COLQ gene.
COLQ anchors AChE to the endplate in the neuromus-
cular junction, and defects in this gene cause abnormal
accumulation of acetylcholine and lead to chronic my-
asthenia. In the compound-heterozygous individual
studied, one of the disease alleles carries an ArG tran-
sition at a site within a splice-donor sequence. Although
the wild-type A nucleotide is predicted to interact with
a complementary nucleotide in the U1 snRNA, which
mediates splice-donor–site recognition, G nucleotides
are found at this position nearly as frequently as A nu-
cleotides, raising the question of why this mutation
should be associated with inaccurate splicing. Ohno et
al. have generated a minigene with the mutation, and
they confirm that it causes exon skipping in heterologous
cells. However, after analyzing large numbers of normal
and mutant splice-donor sequences, they determined
that G-containing sequences become more reliant on
complementarity to the U1 sequence at two neighboring
splice-donor sites. The authors verified this conclusion
by introducing compensatory sequence changes into
their minigene construct and by demonstrating accurate
splicing.
Genetic Analysis of Presenile Alzheimer Disease, by
Campion et al. (p. 664)
Campion et al. have surveyed the population of Rouen,
France, for families with histories of early-onset Alz-
heimer disease (EOAD), in which the beginnings of de-
mentia are seen in individuals !61 years of age. In this
city of 1400,000 people, the authors identify 39 pro-
bands, 24 of whom had affected relatives. In five of these
cases, family histories are consistent with simple auto-
somal dominant inheritance, providing an estimate for
the prevalence of autosomal dominant EOAD
(ADEOAD). The authors have screened these families
and 29 other French ADEOAD families, to determine
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whether mutations in the known AD genes might ac-
count for their disorder. In addition to previously re-
ported disease alleles, this search identified four new mis-
sense mutations in the gene for PRESENILIN-1 and one
in the gene for the amyloid precursor protein. None of
the families appear to carry lesions in PRESENILIN-2,
but the other two genes account for 71% of the cases
in this population.
Polymorphic X Inactivation of TIMP-1, by Anderson
and Brown (p. 699)
Genes that are expressed from the inactive copy of the
X chromosome in female cells are said to have escaped
X inactivation. More than 30 genes with this epigenetic
feature have been described, most of them residing in
clusters. Brown and colleagues previously found indi-
cations that genes might escape inactivation in one in-
dividual but not in another. Now, Anderson and Brown
have followed the expression pattern of the X–linked
TIMP1 gene, which had been identified in the original
study, using hybrids made from the somatic cells of
women known to inactivate a specific X chromosome
in virtually all their tissues. This extreme skewing of X
inactivation allows the authors to detect mono- or bial-
lelic TIMP1 expression, and they confirm that this gene
escapes X inactivation in four of eight cell lines. Inter-
estingly, this epigenetic difference appears to be highly
specific for this gene, because four closely linked genes
that flank TIMP1 are uniformly silenced when the X
chromosome that they reside on is inactivated.
Radiosensitivity and Cancer Predisposition, by Roberts
et al. (p. 784)
Previously, Roberts et al. determined that the cells of
women with breast cancer are unusually sensitive to
chromosomal damage induced by ionizing radiation
(IR), a phenotype that is also seen in conditions in which
DNA repair mechanisms are perturbed. Now, these au-
thors provide direct evidence that this cellular IR re-
sponse is under genetic control. They report a dramatic
incidence of lymphocyte hypersensitivity to IR in rela-
tives of patients who are IR hypersensitive, compared
with either control individuals or relatives of patients
with normal radiosensitivity. This feature is character-
istic for an individual and does not vary greatly over a
2-year period, nor does it correlate with age. Roberts et
al. find that they can model the inheritance of the IR
response as a single major locus modified by one minor
locus. They argue that none of the known genes related
to IR sensitivity or to breast cancer susceptibility are
likely to account for this quantitative trait but that some
variant of a still-to-be-identified gene that regulates it is
enriched in families with high incidence of breast cancer.
ADH and ALDH Polymorphisms and Alcoholism, by
Chen et al. (p. 795)
Two classes of genes for metabolic enzymes have been
associated with predisposition to alcoholism: The al-
cohol dehydrogenase genes ADH2 and ADH3, whose
products generate acetaldehyde from ethanol, and the
acetaldehyde dehydrogenase gene ALDH2, whose prod-
uct degrades acetaldehyde. Individuals who carry cata-
lytically activated variants of ADH genes (ADH2*2 and
ADH3*1) or who carry the catalytically inhibited
ALDH2 variant ALDH2*2 appear to be protected from
alcoholism, presumably because the excessive accumu-
lation of acetaldehyde in each case makes it unpleasant
to consume alcohol. In this report, Chen et al. con-
firm these findings, showing that homozygosity for
ALDH2*2 is fully protective from alcoholism, since no
alcoholic individual with this genotype could be found
in their group of 340 Taiwanese alcoholics, although
more than half the control individuals were homozygous
for this allele. The authors also investigate interactions
among the ADH and ALDH genes, and they report that
the apparent effects of ADH3*1 in this population can
be fully explained by disequilibrium with ADH2*2.
They also argue that the protective effects of ADH2*2
are independent of, and function additively with, those
of ALDH2*2. For more on the genetics of alcoholism,
see Reich et al. (in this issue).
Variation in Local Estimates, by Roberts et al. (p. 876)
Each of the authors in this month’s series on psychiatric
genetics emphasizes the need for replication of genetic
linkage in the pursuit of complex traits, but the further
question of exactly what replication might entail has not
been adequately explored. Roberts et al. point out that
regions of highest linkage for such traits often extend
over a considerable portion of a chromosome and that
it is difficult to know whether the identification of a
similarly positioned region of linkage should be consid-
ered independent replication of a single locus—especially
when two studies measure related but distinct pheno-
types. Using simulated data, Roberts and colleagues find
that, when traits are inherited in the complex manner
(with incompleted penetrance, genetic heterogeneity, and
a substantial rate of phenocopies), the standard error in
the estimate of the location may cover 5–10 cM. Con-
ducting studies with very large numbers of families can
reduce this figure, but other remedies, such as screening
with a denser array of markers, are of minimal help.
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